We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current BFRA market cap is 170.36M. The company's latest EPS is EUR -0.6922 and P/E is -0.48.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 6.83M | 3.83M | 5.8M | 11.99M | 7.02M |
| Operating Income | -4.59M | -2.51M | -3.59M | 1.42M | -2.46M |
| Net Income | -5.1M | -2.32M | -3.68M | 530k | -3.14M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 21.11M | 31.27M | 30.35M | 28.79M | 25.74M |
| Operating Income | -17.51M | -2.19M | -10.03M | 39.39M | -43.05M |
| Net Income | -8.88M | -7.36M | -13.02M | 37.75M | -44.17M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 29.04M | 32.73M | 26.9M | 27.57M | 24.02M |
| Total Liabilities | 12.85M | 12.39M | 10.03M | 10.51M | 10.13M |
| Total Equity | 16.19M | 20.34M | 16.87M | 17.06M | 13.89M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 39.13M | 58.36M | 56.39M | 76.13M | 32.73M |
| Total Liabilities | 22.78M | 48.41M | 49.02M | 18.7M | 12.39M |
| Total Equity | 16.36M | 9.96M | 7.38M | 57.43M | 20.34M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | N/A | -3.9M | N/A | -1.3M | N/A |
| Investing | N/A | -981k | N/A | -408k | N/A |
| Financing | N/A | 4.34M | N/A | -390k | N/A |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -13.43M | -32.89M | -2.85M | 30.44M | -3.9M |
| Investing | -511k | 21.05M | 2.87M | -42.26M | -981k |
| Financing | 22.27M | 3.46M | 5.95M | 2.18M | 4.34M |
| Market Cap | 170.36M |
| Price to Earnings Ratio | -0.48 |
| Price to Sales Ratio | 0.82 |
| Price to Cash Ratio | 3.3 |
| Price to Book Ratio | 1.04 |
| Dividend Yield | - |
| Shares Outstanding | 63.81M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.41 (14.04%) |
| Company Name | Biofrontera AG |
| Address |
hemmelrather weg 201 leverkusen 51377 |
| Website | https://www.biofrontera.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
